2026 update on EAU Guidelines for Non-neurogenic Male LUTS

The episode highlights the latest updates to the EAU Guidelines on non-neurogenic male lower urinary tract symptoms, with a focus on a broader, symptom-based approach to diagnosis and management. Key developments include updated guidance on urodynamics, improved initial patient assessment, and the use of guideline algorithms available via the app.

The discussion also covers treatment updates, including new evidence on beta-3 agonists for storage symptoms and the continued role of established surgical options. Endoscopic enucleation is reinforced as the reference ablative treatment, while aquablation is highlighted as an increasingly supported alternative, particularly for patients wishing to preserve ejaculation. Emerging minimally invasive techniques are addressed, with emphasis on the need for further evidence before broader implementation. The episode also introduces a new guideline chapter on detrusor underactivity and underactive bladder, marking an important expansion of scope. It concludes with the expectation that updates to the guidelines may become more frequent as new evidence continues to emerge in this rapidly evolving field.